Total Funding
29
77
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
151204
Retham Technologies is a biotech company that provides a diagnosis of heparin induced thrombocytopenia by enabling rapid HIT testing.
- Daniel Sem: CEO & General Counsel
- Anand Padmanabhan: Co-founder, President & Chief Science Officer
About the Company
Retham Technologies is a biotech business that enables HIT testing to diagnose heparin-induced thrombocytopenia. They develop an IVD assay for patient HIT diagnosis is expected to facilitate timely and appropriate therapy.
